After two remote years, the Decision Science summer courses return to being fully in-person this summer. In both 2020 and 2021 the courses were taught via synchronous ZOOM sessions due to COVID-19 precautions taken by the University, supplemented with additional support that varied by course.
“After 2 years of ‘Zoom-presence,’ I am so excited and looking forward to learning & teaching, as well as meeting my students at Harvard Chan during the next weeks to exchange thoughts on health decision science,” said Uwe Siebert, who teaches RDS 286: Decision Analysis in Clinical Research. This course introduces clinicians and other doctoral and post-doctoral level students to decision analysis methods relevant to clinical decision making, clinical research, and comparative effectiveness research. It is an intensive course meeting daily for the first summer session.
Maria (Myriam) Hunink teaches the continuation course during the second summer session, RDS 288: Methods for Decision Making in Medicine, which deals with intermediate- to advanced-level topics in the field of medical decision making. This course focuses on the practical application of techniques; students learn to apply modeling methods to evaluate the comparative effectiveness and cost-effectiveness of health interventions.
Both courses are offered as part of the Program in Clinical Effectiveness, a joint program of Massachusetts General, Brigham and Womens Hospital, the Harvard Medical School, and the Harvard T.H. Chan School of Public Health, geared particularly to clinicians pursuing quantitative and analytic skills for clinical research or health care administration.
Related news: Robinson Offers Benefit-Cost Analysis Course Online
Related news: Risk Analysis Course Online with James Hammitt